Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Techno Medica Co's EBIT per Share for the
six
months ended in Mar. 2026 was 円204.20.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 was 円242.66.
During the past 12 months, the average EBIT per Share Growth Rate of Techno Medica Co was 28.80% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 7.40% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 2.80% per year.
During the past 10 years, the average EBIT per Share Growth Rate was 3.10% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Techno Medica Co's EBIT per Share or its related term are showing as below:
TSE:6678'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -12.8 Med: 5.2 Max: 15.1
Current: 7.4
During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Techno Medica Co was 15.10% per year. The lowest was -12.80% per year. And the median was 5.20% per year.
TSE:6678's 3-Year EBIT Growth Rate is ranked worse than 52.41% of 685
companies
in the Medical Devices & Instruments industry
Industry Median: 9.6
vs TSE:6678: 7.40
Techno Medica Co (TSE:6678) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Techno Medica Co EBIT per Share Related Terms
Techno Medica Co EBIT per Share Historical Data
* Premium members only.
The historical data trend for Techno Medica Co's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was 円242.66
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Techno Medica Co (TSE:6678) has a EBIT per Share of 円242.66 as of Mar. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Techno Medica Co and its competitors. According to the industry distribution chart, Techno Medica Co ranks #359 out of 685 companies in the Medical Devices & Instruments industry, placing it in the top 52.4%.
Is Techno Medica Co's EBIT per Share too high?
Techno Medica Co's current EBIT per Share is 円242.66. Based on the distribution chart, Techno Medica Co ranks #359 out of 685 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Techno Medica Co has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Techno Medica Co's EBIT per Share compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Techno Medica Co ranks #359 out of 685 companies for EBIT per Share. This places Techno Medica Co in the lower half of its industry. The industry median EBIT per Share is 9.60. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Medical Devices & Instruments company?
The median EBIT per Share among Medical Devices & Instruments companies is 9.60, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Techno Medica Co and its competitors. For the Medical Devices & Instruments industry, the median EBIT per Share is 9.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Techno Medica Co's current EBIT per Share is 円242.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Techno Medica Co stock overvalued right now?
Based on GuruFocus' analysis, Techno Medica Co (TSE:6678) is currently considered Modestly Undervalued. The stock's GF Value™ is 円2,427.17, compared to a current price of 円2,070.00 — trading 14.7% below its estimated fair value. The current EBIT per Share is 円242.66. Techno Medica Co's overall GF Score™ is 86/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Techno Medica Co (TSE:6678), the current EBIT per Share is 円242.66 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Techno Medica Co (TSE:6678) Overvalued in 2026?
Based on GuruFocus' analysis, Techno Medica Co stock appears to be undervalued.
The current stock price of 円2,070.00 is trading 14.7% below its estimated GF Value™ of 円2,427.17.
GuruFocus considers Techno Medica Co to be Modestly Undervalued.
Key valuation signals for TSE:6678:
EBIT per Share: 円242.66
GF Value™: 円2,427.17 vs. price of 円2,070.00 (14.7% below fair value)
No single metric tells the full story. See the TSE:6678 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Techno Medica Co Ltd is engaged in the research, development, manufacturing, and sales of medical and in vitro diagnostic products. The company's products classified under Test Tube preparation systems. Additionally, company also import and export medical equipment and Analytical instrument for clinical examination.
86GF Score
Get the complete analysis for TSE:6678
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6678 has been successfully added to your 
